The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...

The Food and Drug Administration cited AbbVie for making misleading claims about a migraine pill in TV ads featuring tennis ...

The FDA has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena ...

A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure ...

In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk ...

The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena ...

According to a letter released by the FDA, the advertisement makes false or misleading claims about the drug's efficacy in treating migraine pain. The agency added that the ad exaggerates the speed ...

AbbVie’s TV spots say all patients who take the drug, called Ubrelvy, can expect their migraine pain to be eliminated after a ...

The FDA (Food and Drug Administration) recently sent a letter expressing its dissatisfaction with a TV commercial featuring ...

AbbVie Inc. s TV advertisements featuring tennis legend Serena Williams make misleading claims about the effectiveness of its ...